Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Journal of Surgical Education
|
August 28, 2018
Case Difficulty, Postgraduate Year, and Resident Surgeon Stress: Effects on Operative Times
Jacob A Quick, Alex D Bukoski, Jennifer Doty, et al.
European Journal of Cancer Care
|
February 15, 2019
Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre
Alison Hiong, Karin A Thursky, Georgina Venn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 21, 2023
Drivers and barriers to COVID-19 vaccination in Australians with cancer
Christie Allan, Amelia Hyatt, Amanda Appathurai, et al.
Immunological Reviews
|
June 19, 2013
HIV and co-infections
Christina C Chang, Megan Crane, Jingling Zhou, et al.
Biology of Reproduction
|
May 30, 2008
Molecular identification of lyso-glycerophosphocholines as endogenous immunosuppressives in bovine and rat gonadal fluids
Lynda M Foulds, Reinhard I Boysen, Megan Crane, et al.
The Journal of Infectious Diseases
|
February 24, 2009
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy
Megan Crane, Ben Oliver, Gail Matthews, et al.
Journal of Virology
|
January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy
Megan Crane, Sunee Sirivichayakul, J Judy Chang, et al.
AIDS (London, England)
|
November 17, 2022
Pro-fibrogenic role of alarmin high mobility group box 1 in HIV-hepatitis B virus coinfection
Kasha P Singh, Laura J Pallett, Harsimran Singh, et al.
Ebiomedicine
|
March 22, 2024
Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy
Kasha P Singh, Anchalee Avihingsanon, Jennifer M Zerbato, et al.
The Journal of Infectious Diseases
|
March 4, 2014
Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy
Megan Crane, Anchalee Avihingsanon, Reena Rajasuriar, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Journal of Surgical Education
|
August 28, 2018
Case Difficulty, Postgraduate Year, and Resident Surgeon Stress: Effects on Operative Times
Jacob A Quick, Alex D Bukoski, Jennifer Doty, et al.
European Journal of Cancer Care
|
February 15, 2019
Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre
Alison Hiong, Karin A Thursky, Georgina Venn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 21, 2023
Drivers and barriers to COVID-19 vaccination in Australians with cancer
Christie Allan, Amelia Hyatt, Amanda Appathurai, et al.
Immunological Reviews
|
June 19, 2013
HIV and co-infections
Christina C Chang, Megan Crane, Jingling Zhou, et al.
Biology of Reproduction
|
May 30, 2008
Molecular identification of lyso-glycerophosphocholines as endogenous immunosuppressives in bovine and rat gonadal fluids
Lynda M Foulds, Reinhard I Boysen, Megan Crane, et al.
The Journal of Infectious Diseases
|
February 24, 2009
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy
Megan Crane, Ben Oliver, Gail Matthews, et al.
Journal of Virology
|
January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy
Megan Crane, Sunee Sirivichayakul, J Judy Chang, et al.
AIDS (London, England)
|
November 17, 2022
Pro-fibrogenic role of alarmin high mobility group box 1 in HIV-hepatitis B virus coinfection
Kasha P Singh, Laura J Pallett, Harsimran Singh, et al.
Ebiomedicine
|
March 22, 2024
Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy
Kasha P Singh, Anchalee Avihingsanon, Jennifer M Zerbato, et al.
The Journal of Infectious Diseases
|
March 4, 2014
Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy
Megan Crane, Anchalee Avihingsanon, Reena Rajasuriar, et al.
Page
of 3